Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
mGlu
5
negative allosteric modulators: a patent review (2013 - 2016)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'mGlu
5
negative allosteric modulators: a patent review (2013 - 2016)'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Small Molecules
100%
Metabotropic Glutamate Receptor 5 (mGluR5)
100%
MGlu5 NAM
100%
Negative Allosteric Modulator
100%
Patent Review
100%
Chemotype
75%
Clinical Trials
50%
Disubstituted
50%
Alkynes
50%
Psychiatric Disorders
25%
Neurodegenerative Diseases
25%
Expert Opinion
25%
Area Cover
25%
Patent Application
25%
Mature Field
25%
Multiple Compounds
25%
Clinical Activity
25%
Clinical Compounds
25%
Pharmacology, Toxicology and Pharmaceutical Science
Allosteric Modulator
100%
Clinical Trial
100%
Alkyne
100%
Disease
50%
Preclinical Study
50%